$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Medical drugs
Medical drugs
Medical drugs-Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
The popular anti-cancer targeted drug Erdafitinib has been launched in China but the price is high. How can patients break through the price barrier without medical insurance?
2026-02-01 22:25:32
Check Details
What type of new anti-cancer targeted drugs does Tarlatamab belong to?
2026-02-01 22:25:32
Check Details
How much does a box of Elafibranor cost?
2026-02-01 22:25:32
Check Details
What is the average life expectancy after treatment with Thiotepa?
2026-02-01 22:25:32
Check Details
Is Donanemab a targeted drug or an antibody drug?
2026-02-01 22:25:32
Check Details
Which one is more effective, Vorasidenib or Ensidipine?
2026-02-01 22:25:32
Check Details
Is Seladelpar a new selective PPARδ agonist?
2026-02-01 22:25:32
Check Details
Which generation of EGFR targeted inhibitor drugs does Lazertinib belong to?
2026-02-01 22:25:32
Check Details
Detailed introduction to the main functions and efficacy of Bortezomib
2026-02-01 22:25:32
Check Details
Rheumatoid arthritis can be effective after several injections of Adalimumab
2026-02-01 22:25:32
Check Details
Is Tislelizumab a chemotherapy drug?
2026-02-01 22:25:32
Check Details
How long does it take for ustekinumab to be effective in treating psoriasis?
2026-02-01 22:25:32
Check Details
1
2
...
1693
1694
1695
1696
1697
1698
1699
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
RAS Targeted Therapy Resistance Breakthrough: mTORC1 is Key, Dalifarnib Combination Therapy Brings Hope
2
ARID1A Gene: A New Breakthrough in Tumor Immunotherapy, Turning "Cold Tumors" Hot
3
User Agreement
4
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
5
What is the most important information I should know about WELIREG?
6
How to take and store WELIREG
7
How to take TRUSELTIQ correctly
8
How to deal with LONSURF side effects (1)
9
How to deal with LONSURF side effects (2)
10
Cabozantinib (Cabometyx)-new indication approved
11
What should I pay attention to when using atezolizumab/Tecentriq?
12
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma